1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Sepsis Diagnostics Market – By Product

1.3.2        Asia Pacific Sepsis Diagnostics Market – By Technology

1.3.3        Asia Pacific Sepsis Diagnostics Market – By Method

1.3.4        Asia Pacific Sepsis Diagnostics Market – By Test Type

1.3.5        Asia Pacific Sepsis Diagnostics Market – By Pathogen

1.3.6        Asia Pacific Sepsis Diagnostics Market – By End User

1.3.7        Asia Pacific Sepsis Diagnostics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Sepsis Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Sepsis Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Incidence of Sepsis due to Increasing Nosocomial Infections

5.1.2        Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches

5.2         Market Restraints

5.2.1        Lack of Skilled Professionals

5.3         Market Opportunities

5.3.1        Increase in Funding and Support for Sepsis Diagnostics Research

5.4         Future Trends

5.4.1        Rising Technological Advancements in Sepsis Diagnosis

5.5         Impact Analysis

6.           Sepsis Diagnostics Market–Asia Pacific Analysis

6.1         Asia Pacific Sepsis Diagnostics Market Revenue Forecast and Analysis

7.           Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         Asia Pacific Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)

7.3         Instruments

7.3.1        Overview

7.3.2        Instruments: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Reagents and Assays

7.4.1        Overview

7.4.2        Reagents and Assays: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Blood Culture Media

7.5.1        Overview

7.5.2        Blood Culture Media: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Software

7.6.1        Overview

7.6.2        Software: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Technology

8.1         Overview

8.2         Asia Pacific Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

8.3         Molecular Diagnostics

8.3.1        Overview

8.3.2        Molecular Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Polymerase Chain Reaction

8.3.2.1.1          Overview

8.3.2.1.2          Polymerase Chain Reaction: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Peptide Nucleic Acid-Fluorescent in Situ Hybridization

8.3.2.2.1          Overview

8.3.2.2.2          Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.3          Syndromic Panel-Based Testing

8.3.2.3.1          Overview

8.3.2.3.2          Syndromic Panel-Based Testing: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.4          Microarrays

8.3.2.4.1          Overview

8.3.2.4.2          Microarrays: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Flow Cytometry

8.4.1        Overview

8.4.2        Flow Cytometry: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.3        Real-Time Cell Analysis

8.4.3.1          TaqMan-Based Multiplex RT PCR and Blood Culture

8.4.3.1.1          Characteristics of TaqMan Assays

8.4.3.2          Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) – Case Study

8.4.3.2.1          Abstract

8.4.3.2.2          Conclusion:

8.4.3.3          Companies that are engaged in providing Sepsis Diagnostic solutions

8.4.3.4          Sepsis diagnosis by real-time PCR

8.4.3.5          New next-generation sequencing technique and technological advancements/innovations

8.4.3.6          Real Time Cellular Analysis Using Impedance Measurements

8.4.4        Real-Time Cell Analysis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         Microfluidics

8.5.1        Overview

8.5.2        Microfluidics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6         Immunoassay

8.6.1        Overview

8.6.2        Immunoassay: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7         Biomarkers

8.7.1        Overview

8.7.2        Biomarkers: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.3        Metabolomics

8.7.3.1          Metabolite Profile in Sepsis

8.7.3.2          Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis

8.7.3.3          Early Prediction of Sepsis by Metabolite Profiling

8.7.3.4          Future Role of Omics in Diagnosis and Therapy of Sepsis

8.7.3.4.1          Genomics

8.7.3.4.2          Proteomics

8.7.3.5          Sepsis Biomarkers and Diagnostic Tools

8.7.3.6          Role Metabolomics and Proteomics in Sepsis

8.7.3.7          Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis

8.7.3.8          Recent Application of Metabolomics in Sepsis Diagnosis

8.7.3.9          Metabolics in Mitochondrial Function

8.7.3.10       Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine

8.7.4        Metabolomics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8         Microbiology

8.8.1        Overview

8.8.2        Microbiology: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Method

9.1         Overview

9.2         Asia Pacific Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

9.3         Automated Diagnostics

9.3.1        Overview

9.3.2        Automated Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Conventional Diagnostics

9.4.1        Overview

9.4.2        Conventional Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Test Type

10.1      Overview

10.2      Asia Pacific Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

10.3      Point-of-Care Tests

10.3.1     Overview

10.3.2     Point-of-Care Tests: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4      Laboratory Tests

10.4.1     Overview

10.4.2     Laboratory Tests: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.        Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Pathogen

11.1      Overview

11.2      Asia Pacific Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

11.3      Bacterial Sepsis

11.3.1     Overview

11.3.2     Bacterial Sepsis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.4      Fungal Sepsis

11.4.1     Overview

11.4.2     Fungal Sepsis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.5      Others

11.5.1     Overview

11.5.2     Others: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.        Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – End User

12.1      Overview

12.2      Asia Pacific Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

12.3      Hospitals

12.3.1     Overview

12.3.2     Hospitals: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.4      Pathology and Reference Laboratories

12.4.1     Overview

12.4.2     Pathology and Reference Laboratories: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.5      Others

12.5.1     Overview

12.5.2     Others: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13.        Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 –Country Analysis

13.1      Overview

13.1.1     Asia Pacific Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.1.1.1       China: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.1       China: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.2       China: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.1.3       China: Asia Pacific Sepsis Diagnostics Market, by Technology, 2019–2028 (USD Million)

13.1.1.1.3.1    Biomarkers: Metabolomics 2019-2028

13.1.1.1.3.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.1.3.3    China Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.4       China: Asia Pacific Sepsis Diagnostics Market, by Method, 2019–2028 (USD Million)

13.1.1.1.5       China: Asia Pacific Sepsis Diagnostics Market, by Test Type, 2019–2028 (USD Million)

13.1.1.1.6       China: Asia Pacific Sepsis Diagnostics Market, by Pathogen, 2019–2028 (USD Million)

13.1.1.1.7       China: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.2       Japan: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.1       Japan: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.2       Japan: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.2.3       Japan: Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.2.3.1    Biomarkers: Metabolomics 2019-2028

13.1.1.2.3.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.2.3.3    Japan Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.4       Japan: Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.2.5       Japan: Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.2.6       Japan: Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.2.7       Japan: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.3       India: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.1       India: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.2       India: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.3.3       India: Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.3.3.1    Biomarkers: Metabolomics 2019-2028

13.1.1.3.3.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.3.3.3    India Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.4       India: Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.3.5       India: Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.3.6       India: Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.3.7       India: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.4       Australia: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.4.1       Australia: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.4.2       Australia: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.4.3       Australia: Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.4.3.1    Biomarkers: Metabolomics 2019-2028

13.1.1.4.3.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.4.3.3    Australia Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.4.4       Australia: Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.4.5       Australia: Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.4.6       Australia: Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.4.7       Australia: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.5       South Korea: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.5.1       South Korea: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.5.2       South Korea: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.5.3       South Korea: Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.5.3.1    Biomarkers: Metabolomics 2019-2028

13.1.1.5.3.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.5.3.3    South Korea Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.5.4       South Korea: Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.5.5       South Korea: Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.5.6       South Korea: Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.5.7       South Korea: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.6       Rest of Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.6.1       Rest of Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.6.2       Rest of Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.6.3       Rest of Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.6.3.1    Biomarkers: Metabolomics 2019-2028

13.1.1.6.3.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.6.3.3    Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.6.4       Rest of Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.6.5       Rest of Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.6.6       Rest of Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.6.7       Rest of Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

14.        Sepsis Diagnostics Market–Industry Landscape

14.1      Overview

14.2      Growth Strategies in the Sepsis Diagnostics Market (%)

14.3      Organic Developments

14.3.1     Overview

14.4      Inorganic Developments

14.4.1     Overview

15.        Company Profiles

15.1      Abbott

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      F. HOFFMANN-LA ROCHE LTD.

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Immunexpress Inc.

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      BD

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      Danaher (Beckman Coulter)

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6      Luminex Corporation

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7      THERMO FISHER SCIENTIFIC INC.

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8      bioMerieux SA

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Products and Services

15.8.4     Financial Overview

15.8.5     SWOT Analysis

15.8.6     Key Developments

15.9      T2 Biosystems, Inc.

15.9.1     Key Facts

15.9.2     Business Description

15.9.3     Products and Services

15.9.4     Financial Overview

15.9.5     SWOT Analysis

15.9.6     Key Developments

16.        Appendix

16.1      About the Insight Partners

16.2      Glossary of Terms

LIST OF TABLES

Table 1.             New next-generation sequencing techniques by Company

Table 2.             China: Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             China: Asia Pacific Sepsis Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 4.             China: Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and forecast to 2028 (USD Million)

Table 5.             China: Asia Pacific Sepsis Diagnostics Market, by Method– Revenue and forecast to 2028 (USD Million)

Table 6.             China: Asia Pacific Sepsis Diagnostics Market, by Test Type– Revenue and forecast to 2028 (USD Million)

Table 7.             China: Asia Pacific Sepsis Diagnostics Market, by Pathogen – Revenue and forecast to 2028 (USD Million)

Table 8.             China: Asia Pacific Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan: Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 10.          Japan: Asia Pacific Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 11.          Japan: Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 12.          Japan: Asia Pacific Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 13.          Japan: Asia Pacific Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          Japan: Asia Pacific Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 15.          Japan: Asia Pacific Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 16.          India: Asia Pacific Sepsis Diagnostics Market, By Product– Revenue and Forecast to 2028(USD Million)

Table 17.          India: Asia Pacific Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 18.          India: Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 19.          India: Asia Pacific Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 20.          India: Asia Pacific Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 21.          India: Asia Pacific Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 22.          India: Asia Pacific Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 23.          Australia: Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 24.          Australia: Asia Pacific Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 25.          Australia: Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 26.          Australia: Asia Pacific Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 27.          Australia: Asia Pacific Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 28.          Australia: Asia Pacific Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 29.          Australia: Asia Pacific Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 30.          South Korea: Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 31.          South Korea: Asia Pacific Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 32.          South Korea: Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 33.          South Korea: Asia Pacific Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 34.          South Korea: Asia Pacific Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 35.          South Korea: Asia Pacific Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 36.          South Korea: Asia Pacific Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 37.          Rest of Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 38.          Rest of Asia Pacific Sepsis Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 39.          Rest of Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 40.          Rest of Asia Pacific Sepsis Diagnostics Market, By Method– Revenue and Forecast to 2028 (USD Million)

Table 41.          Rest of Asia Pacific Sepsis Diagnostics Market, By Test Type– Revenue and Forecast to 2028 (USD Million)

Table 42.          Rest of Asia Pacific Sepsis Diagnostics Market, By Pathogen– Revenue and Forecast to 2028 (USD Million)

Table 43.          Rest of Asia Pacific Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 44.          Recent Organic Growth Strategies in Sepsis Diagnostics Market

Table 45.          Inorganic Developments in the Sepsis Diagnostics Market

Table 46.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Asia Pacific Sepsis Diagnostics Market Segmentation

Figure 2.           Asia Pacific Sepsis Diagnostics Market, By Country

Figure 3.           Asia Pacific Sepsis Diagnostics Market Overview

Figure 4.           Blood Culture Media Segment Held Largest Share of Type Segment in Asia Pacific Sepsis Diagnostics Market

Figure 5.           India is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Asia Pacific Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Asia Pacific Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)

Figure 11.        Instruments: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Reagents and Assays: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Blood Culture Media: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Software: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Asia Pacific Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

Figure 16.        Molecular Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Polymerase Chain Reaction: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.        Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        Syndromic Panel-Based Testing: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        Microarrays: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Flow Cytometry: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        Real-Time Cell Analysis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.        Microfluidics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.        Immunoassay: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        Biomarkers: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.        Metabolomics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27.        Microbiology: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.        Asia Pacific Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

Figure 29.        Automated Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        Conventional Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        Asia Pacific Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

Figure 32.        Point-of-Care Tests: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33.        Laboratory Tests: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34.        Asia Pacific Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

Figure 35.        Bacterial Sepsis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36.        Fungal Sepsis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37.        Others: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 38.        Asia Pacific Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

Figure 39.        Hospitals: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40.        Pathology and Reference Laboratories: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 41.        Others: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 42.        Asia Pacific Sepsis Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 43.        Asia Pacific Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 44.        China: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 45.        Japan: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 46.        India: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 47.        Australia: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 48.        South Korea: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        Rest of Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        Growth Strategies in the Sepsis Diagnostics Market (%)